We present the case of a patient who developed thrombotic thrombocytopenic purpura (TTP) following intravenous injection of Opana(®) ER. TTP reemerged after three months of abstinence with Opana misuse. This case report brings awareness to the possibility of developing TTP in those who misuse Opana, which is a growing concern.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425330 | PMC |
| http://dx.doi.org/10.2147/IMCRJ.S65655 | DOI Listing |
Publication Analysis
Top Keywords
thrombotic thrombocytopenic
8
thrombocytopenic purpura
8
opana® induced
4
induced thrombotic
4
purpura case
4
case patient
4
patient developed
4
developed thrombotic
4
purpura ttp
4
ttp intravenous
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!